£0.03
£0.00 (0.00%)
End-of-day quote: 02/18/2024
AIM:RENE
ReNeuron Group Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
£0.53M | £0.40M | £0.26M | £6.17M | £2.72M | £0.90M | £0.90M | £0.56M | £0.55M | £0.68M | £0.02M | £0.04M | £0.03M | £0.03M | £0.09M | £0.03M | |
| GM % | Gross Margin % |
|
0.00% | 100.00% | 0.00% | -164.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | -233.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
£-0.10 | £-0.10 | £-0.17 | £-0.29 | £-0.36 | £-0.45 | £-0.56 | £-0.50 | £-0.40 | £-0.50 | £-0.50 | £-0.80 | £-1.00 | £-1.30 | £-1.00 | £-2.40 | £-4.40 |
| Div. | Dividends |
|
£0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | |
| Sha. | Shares |
|
57.17m | 57.04m | 56.86m | 31.83m | 31.65m | 31.65m | 31.65m | 31.65m | 17.89m | 17.89m | 7.75m | 6.23m | 6.2m | 4.38m | 1.54m | 1.54m | |
| OCF | Operating Cash Flow |
|
£-7.48M | £-7.41M | £-6.05M | £-14.30M | £-11.95M | £-14.89M | £-12.64M | £-11.92M | £-8.25M | £-6.00M | £-6.02M | £-5.79M | £-5.15M | £-2.63M | £-4.40M | £-6.08M | |
| FCF | Free Cash Flow |
|
£-7.70M | £-7.71M | £-6.08M | £-14.42M | £-12.18M | £-15.12M | £-13.17M | £-12.21M | £-8.63M | £-6.12M | £-6.06M | £-5.82M | £-5.18M | £-2.64M | £-4.43M | £-6.42M | |
| FCFS | Free Cash Flow Per Share |
|
£-0.13 | £-0.14 | £-0.16 | £-0.45 | £-0.39 | £-0.48 | £-0.42 | £-0.47 | £-0.48 | £-0.43 | £-0.81 | £-0.94 | £-1.06 | £-0.81 | £-2.87 | £-4.17 |
